Low FT3 is an independent marker of disease severity in patients hospitalized for COVID-19.

Dutta, Aditya; Jevalikar, Ganesh; Sharma, Rutuja; Farooqui, Khalid J; Mahendru, Shama; Dewan, Arun; Bhudiraja, Sandeep; Mithal, Ambrish

Dutta, Aditya; Jevalikar, Ganesh; Sharma, Rutuja; Farooqui, Khalid J; Mahendru, Shama; Dewan, Arun; Bhudiraja, Sandeep; Mithal, Ambrish.

Afiliación

Dutta A; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.
Jevalikar G; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.
Sharma R; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.
Farooqui KJ; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.
Mahendru S; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.
Dewan A; Institute of Internal Medicine, Max Healthcare, Saket, New Delhi, India.
Bhudiraja S; Institute of Internal Medicine, Max Healthcare, Saket, New Delhi, India.
Mithal A; Institute of Endocrinology and Diabetes, Max Healthcare, Saket, New Delhi, India.

Endocr Connect ; 10(11): 1455-1462, 2021 Nov 11.

Article en En | MEDLINE | ID: mdl-34662295

Palabras clave

COVID-19; hypothyroidism; low FT3; non-thyroidal illness; severity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Endocr Connect Año: 2021 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google